Page last updated: 2024-10-16

carbamates and Crohn Disease

carbamates has been researched along with Crohn Disease in 1 studies

Crohn Disease: A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.

Research Excerpts

ExcerptRelevanceReference
"Genomic DNA from 202 patients with Crohn's disease (CD) and 206 healthy controls was analyzed for the C385A polymorphism in the FAAH gene to address a possible role in humans."1.35Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors. ( Brand, S; Buckley, NE; Emmerdinger, D; Göke, B; Keenan, CM; Lutz, B; Massa, F; Patel, KD; Sharkey, KA; Sibaev, A; Storr, MA; Yüce, B; Zhang, H, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Storr, MA1
Keenan, CM1
Emmerdinger, D1
Zhang, H1
Yüce, B1
Sibaev, A1
Massa, F1
Buckley, NE1
Lutz, B1
Göke, B1
Brand, S1
Patel, KD1
Sharkey, KA1

Other Studies

1 other study available for carbamates and Crohn Disease

ArticleYear
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors.
    Journal of molecular medicine (Berlin, Germany), 2008, Volume: 86, Issue:8

    Topics: Amidohydrolases; Animals; Arachidonic Acids; Benzamides; Cannabinoid Receptor Modulators; Carbamates

2008